sweetFrog to Host Alex’s Lemonade Stands
Aug 08, 2017 11:13 am UTC| Business
Richmond, VA, Aug. 08, 2017 -- sweetFrog Frozen Yogurt, the nation’s leading frozen yogurt chain, named America’s Best Frozen Yogurt by The Daily Meal and a Top New Franchise by Entrepreneur Magazine, has announced...
Advanced Materials for Displays 2016-2022: Technologies and Global Markets Report 2017
Aug 08, 2017 11:11 am UTC| Business
Dublin, Aug. 08, 2017 -- The "Advanced Materials for Displays: Technologies and Global Markets" report has been added to Research and Markets' offering. The Global Market for...
Voyager Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Highlights
Aug 08, 2017 11:05 am UTC| Business
CAMBRIDGE, Mass., Aug. 08, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today reported its second quarter...
Aug 08, 2017 11:03 am UTC| Business
Dublin, Aug. 08, 2017 -- The "Connected Medical Device Technologies: Global Markets for Sensors, Platforms and Processors" report has been added to Research and Markets' offering. ...
Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia
Aug 08, 2017 11:01 am UTC| Business
Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, announced today that it has received marketing approval of Doxophos in Russia, a key milestone...
Hamilton Lane Incorporated Reports First Quarter Fiscal 2018 Results
Aug 08, 2017 11:01 am UTC| Business
BALA CYNWYD, Pa., Aug. 08, 2017 -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the first quarter of fiscal year 2018, the period ended June 30,...
Stemline Therapeutics Reports Second Quarter 2017 Financial Results
Aug 08, 2017 11:01 am UTC| Business
NEW YORK, Aug. 08, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial results for the...